BDBM466501 US10799605, Example 12

SMILES COc1cccc(OC)c1-c1cc(nn1-c1ccc(cc1C(C)C)C(=O)N(C)CCCN(C)CCCN(C)C(=O)CCC(=O)NCCCOCCOCCOCCCNC(=O)CCC(N1CCN(CC(O)=O)CCN(CC(O)=O)CC1)C(O)=O)C(=O)NC1(C2CC3CC(C2)CC1C3)C(O)=O

InChI Key InChIKey=JBWZSQAATPMTHP-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 466501   

TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466501(US10799605, Example 12)
Affinity DataIC50:  4.90nMAssay Description:In order to determine the binding affinity of compounds comprising a radiolabel for NTR1, a radioligand binding assay was carried out. A radioligand ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeurotensin receptor type 1(Homo sapiens (Human))
3B Pharmaceuticals

US Patent
LigandPNGBDBM466501(US10799605, Example 12)
Affinity DataIC50:  21.4nMAssay Description:Ca2+ ions are usually kept at nanomolar levels in the cytosol of cells, and act in a number of signal transduction pathways as second messengers. Man...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent